TITLE

Study of pulmonary involvement in HIVseropositive patients

AUTHOR(S)
Nair, Girija; Deshmukh, Hafiz; Jayalakshmi, T. K.; Uppe, Abhay; Modi, Kavita
PUB. DATE
January 2012
SOURCE
BMC Infectious Diseases;2012 Supplement, Vol. 12 Issue Supplment 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study on the pulmonary risks involved in HIV-seropositive patients in India. The author investigates the exposure of HIV patients to pulmonary tuberculosis secondary to HIV infection. They state that such conditions may be a major cause of morbidity and mortality among HIV-positive patients.
ACCESSION #
76592316

 

Related Articles

  • Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Campos, Pablo E.; Suarez, Pedro G.; Sanchez, Jorge; Zavala, David; Arevalo, Jorge; Ticona, Eduardo; Nolan, Charles M.; Hooton, Thomas M.; Holmes, King K. // Emerging Infectious Diseases;Dec2003, Vol. 9 Issue 12, p1571 

    During 1999 to 2000, we identified HIV-infected persons with new episodes of tuberculosis (TB) at 10 hospitals in Lima, Peru, and a random sample of other Lima residents with TB. Multidrug-resistant (MDR)-TB was documented in 35 (43%) of 81 HIV-positive patients and 38 (3.9%) of 965 patients...

  • Tuberculosis-HIV co-infection among patients admitted at Muhimbili National Hospital in Dar es salaam, Tanzania. Kamenju, Pili; Aboud, Said // Tanzania Journal of Health Research;Feb2011, Vol. 13 Issue 1, p25 

    Data on the clinical presentations and magnitude of tuberculosis (TB)-human immunodeficiency virus (HIV) co-infection is limited. The objective of this study was to describe the clinical presentation and prevalence of TB-HIV co-infection among patients admitted at Muhimbili National Hospital...

  • TB and HIV: how can we reduce mortality? Lawn, S. // Journal of the International AIDS Society;2012 Supplement 4, Vol. 15 Issue Supp 4, p1 

    An abstract of the article by S. Lawn regarding ways to reduce mortality in tuberculosis (TB) and HIV-positive patients is presented.

  • HIV Counseling, Testing, and Care of Tuberculosis Patients at Chest Clinics -- Guyana, 2005-2006. Persaud, S.; Mohanlall, J.; Bateganya, M.; Anude, C. // MMWR: Morbidity & Mortality Weekly Report;8/11/2006, Vol. 55 Issue 31, p848 

    This report summarizes the results of an assessment of tuberculosis (TB) as a leading cause of morbidity and mortality among persons living with HIV/AIDS in Guyana from 2005 to 2006. The results indicate a high rate of HIV infection among TB patients in the country. The ability of chest clinics...

  • Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. Mayanja-kizza, Harriet; Jones-lopez, Edward; Okwera, Alphonse; Wallis, Robert S.; Elmer, Jerrold J.; Muqerwa, Roy D.; Whalen, Christopher C.; Ellner, Jerrold J; Mugerwa, Roy D; Uganda-Case Western Research Collaboration // Journal of Infectious Diseases;3/15/2005, Vol. 191 Issue 6, p856 

    Background. Human immunodeficiency virus (HIV)-infected patients with tuberculosis (TB) respond to effective antituberculous therapy, but their prognosis remains poor. Mounting evidence from clinical studies supports the concept of copathogenesis in which immune activation that is triggered by...

  • Viral Decay Rates are Similar in HIV-infected Patients with and without TB Coinfection during Treatment with an Efavirenz-based Regimen. Lartey, Margaret; Sagoe, Kwamena W.; Hongmei Yang; Kenu, Ernest; Xexemeku, Fafa; Oliver-Commey, Joseph; Boima, Vincent; Seshie, Markafui; Sagoe, Augustine; Mingle, Julius A. A.; Flanigan, Timothy P.; Hulin Wu; Kwara, Awewura // Clinical Infectious Diseases;2/15/2011, Vol. 52 Issue 4, p547 

    Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were...

  • A Diagnostic Accuracy Study of Xpert MTB/RIF in HIVPositive Patients with High Clinical Suspicion of Pulmonary Tuberculosis in Lima, Peru. Carriquiry, Gabriela; Otero, Larissa; González-Lagos, Elsa; Zamudio, Carlos; Sánchez, Eduardo; Nabeta, Pamela; Campos, Miguel; Echevarría, Juan; Seas, Carlos; Gotuzzo, Eduardo // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Background: Diagnosis of pulmonary tuberculosis (TB) among human immunodeficiency virus (HIV) patients remains complex and demands easy to perform and accurate tests. Xpert®MTB/RIF (MTB/RIF) is a molecular TB diagnostic test which is rapid and convenient; the test requires minimal human...

  • Pneumonia por Pneumocystis jiroveci (PPC) em pacientes com SIDA atendidos em hospitais da Baixada Fluminense, Rio de Janeiro, Brasil. Norberg, Antonio Neres; Melo Reis, Carlos Henrique; De Carvalho Queiroz, Margareth Maria; Ribeiro, Paulo César; Pile, Edwin; De Carvalho, Raimundo Wilson // Colombia Medica;abr-jun2009, Vol. 40 Issue 2, p213 

    Objetives: The authors investigated the P. jiroveci prevalence and the epidemiological pattern of individuals with HIV infection and pulmonary infection concomitantly. Method: Were collected 266 samples of bronchoalveolar lavae of the HIV infection patients from three hospitals from Baixada...

  • Tuberculosis and the Immune Reconstitution Inflammatory Syndrome. Macher, Abe; Kibble, Deborah; Schuster-Walker, Marmie // American Jails;Sep/Oct2004, Vol. 18 Issue 4, p39 

    Presents cases that demonstrate some of the diverse clinical presentations of HIV-infected patients with immune reconstitution inflammatory syndrome (IRIS) associated with tuberculosis. Paradoxical unmasking of tuberculosis following initiation of antiretroviral therapy; Paradoxical exacerbation...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics